MB, Levis & Associates’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDS
CAI
CIA
MMA
ACA
RJFSA
MB, Levis & Associates's IBDS Position: Q4 2023 in Review
MB, Levis & Associates sold out of iShares iBonds Dec 2027 Term Corporate ETF (IBDS) in Q4 2023, closing a stake of 197 shares — an estimated $4.56K sold.
MB, Levis & Associates first reported a position in IBDS in Q4 2022 and held it in 4 quarters. The position peaked at $4.61K in Q1 2023. 270 funds tracked by Wall St. Rank hold IBDS as of Q4 2023.
- MB, Levis & Associates reported no remaining iShares iBonds Dec 2027 Term Corporate ETF position as of Q4 2023 after selling out during the quarter.
- MB, Levis & Associates sold 197 iShares iBonds Dec 2027 Term Corporate ETF shares in Q4 2023, an estimated $4.56K.
- MB, Levis & Associates first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2022 and held it in 4 quarters.
- MB, Levis & Associates's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $4.61K in Q1 2023.
- 270 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q4 2023.
Based on MB, Levis & Associates's 13F filing for Q4 2023, filed 7 May 2025.